Empresa Oragenics Inc Nyse
Acciones
US6840232036
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Medical Products
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -71,37 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -71,37 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Redmond
CEO | Chief Executive Officer | 64 | 28/12 |
Janet Huffman
DFI | Director of Finance/CFO | 52 | 07/03/23 |
Kimberly Murphy
BRD | Director/Board Member | 62 | 01/05/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Charles Pope
CHM | Chairman | 73 | 04/06/10 |
John Gandolfo
BRD | Director/Board Member | 63 | 04/10/23 |
Robert Koski
BRD | Director/Board Member | 65 | 30/06/09 |
Director/Board Member | 73 | 01/06/10 | |
Alan Dunton
BRD | Director/Board Member | 70 | 01/04/11 |
Bruce Cassidy
BRD | Director/Board Member | 74 | 04/10/23 |
Kimberly Murphy
BRD | Director/Board Member | 62 | 01/05/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 7 488 692 | 0 | 0 | 76,77 % |
Acción B | 0 | 4 050 000 | 0 | 0 | |
Acción C | 1 | 4 480 693 | 3 439 769 ( 76,77 %) | 0 | |
Acción D | 0 | 5 417 000 | 0 | 0 |
Información de la empresa
Oragenics, Inc.
4902 Eisenhower boulevard Suite 125
33634-6310, Tampa
+813 286 7900
http://www.oragenics.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,61 % | 122 mil M | |
+17,75 % | 112 mil M | |
+17,23 % | 25,91 mil M | |
-24,11 % | 19,33 mil M | |
-18,56 % | 16,17 mil M | |
-18,47 % | 15,6 mil M | |
-47,75 % | 14,65 mil M | |
+57,35 % | 14,34 mil M | |
+5,62 % | 14 mil M |